Welcome
to the Lipedema Society.
Awareness, Education, Research and Advocacy for Lipedema and
other Fat Disorders.
Advancing the clinical understanding, diagnosis and treatment of lipedema and other fat disorders..
Founded in 2015, the Lipedema Society (LS) was the first USA medical society dedicated to raising awareness, educating and sharing best practices for the treatment of lipedema.
Today the Lipedema Society is a U.S. national
public-benefit nonprofit corporation governed by a multidisciplinary board of physicians and healthcare professionals, operating under Section 501(c)(3) of the Internal Revenue Code (status pending).
Our Mission is to advance the understanding, diagnosis, and treatment of lipedema and other fat disorders by turning research, frontline clinical expertise and real-world evidence into publicly available clinical guidance, standards of care, medical education, and certification programs. Our long-term vision includes integrating lipedema education into medical school curricula.
We collaborate with academic and aligned partners on research, awareness and education initiatives to inform patients, clinicians, insurers, and policymakers. We support earlier diagnosis, consistent high-quality care, and access to medically necessary treatment, helping patients receive the right care, at the right time, from qualified experts.
About Us
At it's inception, the Lipedema Society (LS) identified a critical lack of healthcare providers who were diagnosing and treating lipedema patients. This highlighted the need for a network of leading clinicians, surgeons and academics to share best practices and advance the field of lipedema and care of patients. While the global lipedema community has made significant progress, much remains to be done.
Today the Lipedema Society is a national nonprofit public benefit corporation in the United States, operating under Section 501(c)(3) of the Internal Revenue Code (status pending). LS is governed by a multidisciplinary board of physicians and healthcare professionals, guided by our CEO and executive team.
LS advances the clinical understanding, diagnosis, and treatment of lipedema and other fat disorders through awareness, education, research and advocacy activities.
We develop clinical guidance, standards of care and certification programs. We conduct and contribute to research and work with partner academic institutions and aligned organizations to support initiatives that foster awareness, understanding, and evidence-informed practice.
We translate science, real-world evidence, and clinical expertise into clear clinical guidance for patients, clinicians, insurers, and policymakers—so medically necessary treatment from qualified experts reaches people when they need it.
David Amron, MD
Founder Lipedema Society
Dr. David Amron pioneered lipedema surgical techniques in the United States and with 25+ years of experience completing successful and safe lipedema liposuction surgeries, he is a leading authority in the field.
Dr. Amron is a board-certified Dermatologic Surgeon, the Medical Director and Founder of The Roxbury Institute and the Advanced Lipedema Treatment Program. He is the Founder of the Lipedema Society and the current Chair of the Board.
Join The Community!
@LipedemaSociety
Educational Resources
Will be linked here. Check back for updates.
Lipedema Society Board of Directors and Executive Team
will be announced here soon.
Interesting reads from the medical literature.
NIH > National Library of Medicine National Centre for Biotechnology Information
Vyas A, Adnan G. Lipedema. [Updated 2022 Sep 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan.
Available from:
https://www.ncbi.nlm.nih.gov/books/NBK573066/#article-131051.s1
Canadian Journal of Health Technologies
A CADTH Publication
Vol. 2 No. 8 (2022)
Published August 10, 2022
Khai Tran, Jennifer Horton Liposuction for Lipedema: 2022 Update
Available from:
NICE > National Institute for Health and Care Excellence
Liposuction for chronic lipoedema
Interventional procedures guidance [IPG721]
Published: 29 March 2022
Available from:
https://www.nice.org.uk/guidance/ipg721/chapter/2-The-condition-current-treatments-and-procedure
Phlebology: The Journal of Venous Disease
Herbst KL, Kahn LA, Iker E, et al. Standard of care for lipedema in the United States. Phlebology. 2021;36(10):779-796.
Available from:
Neutraceuticals 2022
Published October 3, 2022
Cannataro, R.; Cione, E. Nutritional Supplements and Lipedema: Scientific and Rational Use. Nutraceuticals 2022, 2, 270-277.
Available from:
https://doi.org/10.3390/nutraceuticals2040020
Obesity
A Research Journal
The Obesity Society
Volume 27 Issue 10
October 2019
Buso, G., Depairon, M., Tomson, D., Raffoul, W., Vettor, R. and Mazzolai, L. (2019), Lipedema: A Call to Action!. Obesity, 27: 1567-1576.
Available from:
https://doi.org/10.1002/oby.22597
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Volume 2022:15
Published August 22, 2022
Jeziorek M, Szuba A, Kujawa K, Regulska-Ilow B.
The Effect of a Low-Carbohydrate, High-Fat Diet versus Moderate-Carbohydrate and Fat Diet on Body Composition in Patients with Lipedema.
Diabetes Metab Syndr Obes. 2022;15:2545-2561
Available from:
Quality of Life Research 2022
Published 16 August 2022
Clarke, C., Kirby, J.N., Smidt, T. et al. Stages of lipoedema: experiences of physical and mental health and health care. Qual Life Res (2022).
Available from: